ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review

Pooria Safarzadeh Kozani, Setareh Dashti Shokoohi, Narges Baharifar, Sepideh Sheikhi, Fatemeh Khalaf Shamsabadi, Forough Chamaie Nejad, Mehdi Sheikhi, Mehdi Rabiee Valashedi, Pouya Safarzadeh Kozani, Seyed Mohamad Javad Mirarefin, A. Sheikhi
{"title":"ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review","authors":"Pooria Safarzadeh Kozani, Setareh Dashti Shokoohi, Narges Baharifar, Sepideh Sheikhi, Fatemeh Khalaf Shamsabadi, Forough Chamaie Nejad, Mehdi Sheikhi, Mehdi Rabiee Valashedi, Pouya Safarzadeh Kozani, Seyed Mohamad Javad Mirarefin, A. Sheikhi","doi":"10.5812/tms-130682","DOIUrl":null,"url":null,"abstract":": Angiotensin-converting enzyme 2 (ACE2) is widely known as the essential receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is the cause of the globally known coronavirus disease 2019 (COVID-19) pandemic, which has been the leading cause of virus-related mortality since early 2020. A wide range of human cells in different human organs express ACE2. The importance of ACE2 in the involvement of human organs during COVID-19 and its critical role in the process of target cell infection have rendered it an interesting therapeutic target. In this review, we briefly focus on ACE2 and its general roles in the human body and highlight the roles of ACE2 in the emergence of COVID19. Ultimately, we discuss the strategies for preventing virus entry using ACE2 blocking.","PeriodicalId":408913,"journal":{"name":"Trends in Medical Sciences","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/tms-130682","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: Angiotensin-converting enzyme 2 (ACE2) is widely known as the essential receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is the cause of the globally known coronavirus disease 2019 (COVID-19) pandemic, which has been the leading cause of virus-related mortality since early 2020. A wide range of human cells in different human organs express ACE2. The importance of ACE2 in the involvement of human organs during COVID-19 and its critical role in the process of target cell infection have rendered it an interesting therapeutic target. In this review, we briefly focus on ACE2 and its general roles in the human body and highlight the roles of ACE2 in the emergence of COVID19. Ultimately, we discuss the strategies for preventing virus entry using ACE2 blocking.
ACE2在sars - cov -2介导的COVID-19中的作用:综述
血管紧张素转换酶2 (ACE2)被广泛认为是严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)的重要受体。SARS-CoV-2是全球已知的2019冠状病毒病(COVID-19)大流行的原因,自2020年初以来,该疾病一直是病毒相关死亡的主要原因。ACE2在人体不同器官中的广泛表达。ACE2在COVID-19期间参与人体器官的重要性及其在靶细胞感染过程中的关键作用使其成为一个有趣的治疗靶点。本文简要介绍ACE2及其在人体中的一般作用,并重点介绍ACE2在新冠病毒发生中的作用。最后,我们讨论了使用ACE2阻断阻止病毒进入的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信